Bienville Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bienville Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,866	Closed	-$548K	–	186
2019 Q2	$548K	Sell	1,866 -10	-0.5%	-$2.75K	0.07%	82
2019 Q1	$514K	Sell	1,876 -51	-3%	-$12.7K	0.06%	79
2018 Q4	$432K	Buy	1,927 +1,001	+108%	+$235K	0.08%	82
2018 Q3	$226K	Buy	+926	New	+$213K	0.02%	96
2018 Q1	–	Sell	-1,833	Closed	-$348K	–	198
2017 Q4	$348K	Sell	1,833 -35	-2%	-$6.71K	0.06%	125
2017 Q3	$354K	Buy	1,868 +181	+11%	+$32.8K	0.06%	109
2017 Q2	$295K	Buy	1,687 +27	+2%	+$4.54K	0.08%	116
2017 Q1	$255K	Hold	1,660	–	–	0.06%	124
2016 Q4	$234K	Hold	1,660	–	–	0.05%	124
2016 Q3	$264K	Hold	1,660	–	–	0.07%	112
2016 Q2	$245K	Buy	+1,660	New	+$245K	0.07%	94

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bienville Capital Management's TMO Position: Q3 2019 in Review

Bienville Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2019, closing a stake of 1,866 shares — an estimated $548K sold.

Bienville Capital Management first reported a position in TMO in Q2 2016 and held it in 11 quarters. The position peaked at $548K in Q2 2019. 1,543 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

Bienville Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2019 after selling out during the quarter.
Bienville Capital Management sold 1,866 Thermo Fisher Scientific shares in Q3 2019, an estimated $548K.
Bienville Capital Management first reported a position in Thermo Fisher Scientific in Q2 2016 and held it in 11 quarters.
Bienville Capital Management's Thermo Fisher Scientific position peaked at $548K in Q2 2019.
1,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Bienville Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.